Literature DB >> 22750505

S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.

Julie D Saba1, Anabel S de la Garza-Rodea.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid whose actions are essential for many physiological processes including angiogenesis, lymphocyte trafficking and development. In addition, S1P serves as a muscle trophic factor that enables efficient muscle regeneration. This is due in part to S1P's ability to activate quiescent muscle stem cells called satellite cells (SCs) that are needed for muscle repair. However, the molecular mechanism by which S1P activates SCs has not been well understood. Further, strategies for harnessing S1P signaling to recruit SCs for therapeutic benefit have been lacking. S1P is irreversibly catabolized by S1P lyase (SPL), a highly conserved enzyme that catalyzes the cleavage of S1P at carbon bond C(2-3), resulting in formation of hexadecenal and ethanolamine-phosphate. SPL enhances apoptosis through substrate- and product-dependent events, thereby regulating cellular responses to chemotherapy, radiation and ischemia. SPL is undetectable in resting murine skeletal muscle. However, we recently found that SPL is dynamically upregulated in skeletal muscle after injury. SPL upregulation occurred in the context of a tightly orchestrated genetic program that resulted in a transient S1P signal in response to muscle injury. S1P activated quiescent SCs via a sphingosine-1-phosphate receptor 2 (S1P2)/signal transducer and activator of transcription 3 (STAT3)-dependent pathway, thereby facilitating skeletal muscle regeneration. Mdx mice, which serve as a model for muscular dystrophy (MD), exhibited skeletal muscle SPL upregulation and S1P deficiency. Pharmacological SPL inhibition raised skeletal muscle S1P levels, enhanced SC recruitment and improved mdx skeletal muscle regeneration. These findings reveal how S1P can activate SCs and indicate that SPL suppression may provide a therapeutic strategy for myopathies. This article is part of a Special Issue entitled Advances in Lysophospholipid Research.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750505      PMCID: PMC3609719          DOI: 10.1016/j.bbalip.2012.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  83 in total

Review 1.  Forming a multinucleated cell: molecules that regulate myoblast fusion.

Authors:  Valerie Horsley; Grace K Pavlath
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

Review 2.  Regenerative capacity of skeletal muscle.

Authors:  Janine Ehrhardt; Jennifer Morgan
Journal:  Curr Opin Neurol       Date:  2005-10       Impact factor: 5.710

3.  Translating mighty mice into neuromuscular therapeutics: is bigger muscle better?

Authors:  Eric P Hoffman; Diana Escolar
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.

Authors:  A M Connolly; R M Keeling; S Mehta; A Pestronk; J R Sanes
Journal:  Neuromuscul Disord       Date:  2001-11       Impact factor: 4.296

5.  S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.

Authors:  Padmavathi Bandhuvula; Norman Honbo; Guan-Ying Wang; Zhu-Qiu Jin; Henrik Fyrst; Meng Zhang; Alexander D Borowsky; Lisa Dillard; Joel S Karliner; Julie D Saba
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

6.  Sphingosine 1-phosphate regulates myogenic differentiation: a major role for S1P2 receptor.

Authors:  Chiara Donati; Elisabetta Meacci; Francesca Nuti; Laura Becciolini; Marta Farnararo; Paola Bruni
Journal:  FASEB J       Date:  2004-12-29       Impact factor: 5.191

Review 7.  Pathophysiology of duchenne muscular dystrophy: current hypotheses.

Authors:  Nicolas Deconinck; Bernard Dan
Journal:  Pediatr Neurol       Date:  2007-01       Impact factor: 3.372

Review 8.  Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.

Authors:  Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

Review 9.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

10.  Receptor-mediated activation of phospholipase D by sphingosine 1-phosphate in skeletal muscle C2C12 cells. A role for protein kinase C.

Authors:  E Meacci; V Vasta; C Donati; M Farnararo; P Bruni
Journal:  FEBS Lett       Date:  1999-08-27       Impact factor: 4.124

View more
  13 in total

1.  LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages.

Authors:  Junfei Jin; Zhongyang Lu; Yanchun Li; Ji Hyun Ru; Maria F Lopes-Virella; Yan Huang
Journal:  J Leukoc Biol       Date:  2018-06-08       Impact factor: 4.962

2.  A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia.

Authors:  Tsukasa Shimauchi; Takuro Numaga-Tomita; Yuri Kato; Hiroyuki Morimoto; Kosuke Sakata; Ryosuke Matsukane; Akiyuki Nishimura; Kazuhiro Nishiyama; Atsushi Shibuta; Yutoku Horiuchi; Hitoshi Kurose; Sang Geon Kim; Yasuteru Urano; Takashi Ohshima; Motohiro Nishida
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

3.  Very-long-chain fatty acids restrict regeneration capacity by confining pericycle competence for callus formation in Arabidopsis.

Authors:  Baoshuan Shang; Chongyi Xu; Xixi Zhang; Huifen Cao; Wei Xin; Yuxin Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

4.  Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity.

Authors:  Claudine Hahn; Karolina Tyka; Julie D Saba; Sigurd Lenzen; Ewa Gurgul-Convey
Journal:  J Biol Chem       Date:  2017-10-25       Impact factor: 5.157

Review 5.  Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.

Authors:  Kazuyuki Kitatani; Makoto Taniguchi; Toshiro Okazaki
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

6.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Activation-Induced Cell Death of Dendritic Cells Is Dependent on Sphingosine Kinase 1.

Authors:  Anja Schwiebs; Olga Friesen; Elisabeth Katzy; Nerea Ferreirós; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Pharmacol       Date:  2016-04-15       Impact factor: 5.810

Review 8.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

Review 9.  Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia.

Authors:  Seong-Hoon Yun; Sung-Won Shin; Valentin A Stonik; Joo-In Park
Journal:  Mar Drugs       Date:  2016-11-03       Impact factor: 5.118

10.  Sphingosine kinase 1-associated autophagy differs between neurons and astrocytes.

Authors:  Jose F Moruno-Manchon; Ndidi-Ese Uzor; Chandrashekar R Ambati; Vivekananda Shetty; Nagireddy Putluri; Chinnaswamy Jagannath; Louise D McCullough; Andrey S Tsvetkov
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.